United States
£ GBP
This book presents the opinions of an international panel of specialists that explored the agricultural, commercial, ecological, legal, pharmacological and social future of medicinal and aromatic plants. It represents a wide collection of views, reflecting the diversity of disciplines and interests of the panel members. It highlights the necessity of continued and integrated research on plant sources, conservation, bioactivity, analysis and marketing in examining future scenarios for application and sale of medicinal and aromatic plants. It shows the need for proof of efficacy and safety in drug development and the need to recognize societies contributing plant materials.
The development of safe and effective medicinal and aromatic plant products depends upon the collaborative efforts of growers, collectors, conservationists, processors and businesses along with those of educators, sociologists, researchers and investors in developed and developing societies. This book shows the progress that can be made by further developing this collaboration to enhance the discovery, production and use of medicinal and aromatic plants.
Preface.- Colour pages.- 1. The challenge of non-experimental validation of MAC plants: towards a multivariate model of transcultural utilization of medicinal, aromatic and cosmetic plants.- 2. Medicinal plants and tomorrow?s pharmacy: an American Perspective.- 3. Cultivation of medicinal plants as a tool for biodiversity conservation and poverty alleviation in the Amatola region, South Africa.- 4. onversations with farmers in Sri Lanka.- 5. Connecting the disadvantaged to the uninformed: problematic business communication in medicinal and aromatic plants industry.- 6. A comparison of cultivation and wild collection of medicinal and aromatic plants under sustainability aspects.- 7. Sustainable wild collection of medicinal and aromatic plants: development of an international standard.- 8. Revision of the 'Guidelines on the conservation of medicinal plants? by WHO, IUCN, WWF and TRAFFIC: process and scope.- 9. Intellectual property protection for medicinal and aromatic plants.- 10. Amidst peril and progress: conservation of diversity and patent law- 11. International trade in medicinal and aromatic plants: actors, volumes and commodities.- 12. Designing for development: principles and practices of a sustainable medicinal plant chain in North India.- 13. Devil?s Claw (Harpagophytum procumbens) from Southern Africa: sustainable use by cultivation combined with controlled harvesting in semi-wild populations.- 14. Conservation of Eastern European medicinal plants: Arnica montana in Romania.- 15. What is marketing? A brief introduction to marketing for participants in the MAP industry.- 16. Demand and availability of Rhodiola rosea raw material.- 17. Drying of medicinal plants.- 18. Quality control in the production chain of herbal products.- 19. Plants as source for medicines: new perspectives.- 20. Research to improve artemisinin production for use in the preparation of anti-malarial drugs.- 21. Functional genomic approaches to study and engineer secondary metabolism in plant cell cultures.- 22. The schweinfurthins: issues in the development of a plant derived anticancer lead.
